Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

The era of targeting these proteins at an early stage to minimise risk of Alzheimer’s progressing has started. The prospect ...

Reminiscence refers to the act of recalling memories from the past. It is a familiar activity to everyone, but reminiscence can be highly beneficial for people with Alzheimer’s disease. It can support ...

Earlier this year, the Medicines and Healthcare products Regulatory Agency (MHRA) licensed the first-ever drug to slow progression of Alzheimer’s disease. But the landmark decision for lecanemab ...

"In people with progressive cognitive decline, the diagnosis of Alzheimer's disease requires a demonstration of amyloid and ...

More than six million Americans are affected by Alzheimer's disease ... Ph.D., TTUHSC School of Medicine and Graduate School of Biomedical Sciences Grozdanov explained that alternative ...

A new study, released today in The BMJ, shows that taxi drivers die at lower rates from Alzheimer’s disease than people in other professions — potentially because the job involves exercising ...

Researchers have unveiled a critical mechanism that links cellular stress in the brain to the progression of Alzheimer's disease (AD). The study highlights microglia, the brain's primary immune ...

will investigate how perturbed gene expression in the brain can contribute to neurodegenerative disorders like Alzheimer’s disease. Specifically, Grozdanov’s study will focus on alternative ...